Conavi Medical, a company focused on imaging tech to guide minimally invasive cardiovascular procedures, has revealed strategic leadership changes related to its planned commercial launch and expansion in the U.S.

The company submitted its next-gen Novasight Hybrid IVUS/OCT intravascular imaging system to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. It’s building the infrastructure needed for a successful U.S. launch.

Conavi appointed Mark Quick as chief financial officer (CFO). He will oversee financial strategy and investor engagement as the company prepares for U.S. launch.

Quick boasts over two decades of experience in the medtech and life sciences sectors. Before joining Conavi, he held senior financial leadership positions with publicly traded companies on Nasdaq. Earlier in his career, Quick was a sell-side equity research analyst at Canaccord Genuity, where he covered the medical device industry.

“Conavi has a differentiated and highly compelling technology platform,” said Quick. “I’m excited to join at this stage of growth and look forward to working with the team to advance a strong financial, operational, and capital markets strategy as the Company prepares for commercialization.”

The company also named Stefano Picone to take on a transitional strategic role with the company as chief strategy officer. Picone successfully guided Conavi through its go-public transaction, first public equity financing, and organizational scale-up.

“We are entering a very exciting chapter for Conavi as we prepare for broader U.S. adoption of our hybrid imaging platform,” said Thomas Looby, CEO of Conavi Medical. “Mark brings the ideal financial and strategic mindset to help guide our U.S. launch and expand our presence in the capital markets. Stefano’s leadership over the past decade has been instrumental in establishing the corporate foundation we stand on today, and we are grateful for his significant financial stewardship and continued support as we execute on Conavi’s long-term growth and value-creation strategy. With these leadership enhancements and U.S. expansion activities advancing, we are confident we have the right team, capabilities, and focus in place to deliver success in the United States and create long-term value for shareholders.”